Literature DB >> 25501613

Proportions of patients with HIV retained in care and virally suppressed in New York City and the United States: higher than we thought.

Qiang Xia1, Laura S Kersanske, Ellen W Wiewel, Sarah L Braunstein, Colin W Shepard, Lucia V Torian.   

Abstract

BACKGROUND: The purpose of this analysis is to compare 2 newly developed methods (a "likelihood" method and a "weighting" method) with the widely used method (the "include-all" method) to estimate the proportions of HIV-infected persons retained in care and virally suppressed in New York City (NYC).
METHODS: The NYC HIV registry data were used for the analysis. The include-all method included all patients in the denominator who were diagnosed and/or receiving care in NYC and not known to be dead by December 31, 2012. The likelihood method included patients in the denominator who were likely to reside in NYC in 2012 based on their length of absence from HIV care. The weighting method included patients in the denominator who were residing in NYC in 2012 by weighting each in-care patient based on their probability of receiving HIV care.
RESULTS: The include-all method estimated that 114,926 persons were diagnosed and living with HIV in NYC, 63.7% were retained in care (≥1 care visit in 2012), and 48.9% were virally suppressed (≤200 copies/mL). The likelihood method and the weighting method produced equivalent estimates with 80,074 and 80,509 persons diagnosed and living with HIV in NYC, 91.5% and 91.0% retained in care, and 70.2% and 71.7% virally suppressed, respectively.
CONCLUSIONS: Using 2 newly developed methods, we were able to report more accurate estimates of the proportions of patients retained in care and virally suppressed. Other local health jurisdictions should consider using these new methods to measure care outcomes and monitor the National HIV/AIDS Strategy.

Entities:  

Mesh:

Year:  2015        PMID: 25501613     DOI: 10.1097/QAI.0000000000000464

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

1.  Estimates of the Time From Seroconversion to Antiretroviral Therapy Initiation Among People Newly Diagnosed With Human Immunodeficiency Virus From 2006 to 2015, New York City.

Authors:  McKaylee M Robertson; Sarah L Braunstein; Donald R Hoover; Sheng Li; Denis Nash
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

2.  Reduction in Gaps in High CD4 Count and Viral Suppression Between Transgender and Cisgender Persons Living With HIV in New York City, 2007-2016.

Authors:  Qiang Xia; Selam Seyoum; Ellen W Wiewel; Lucia V Torian; Sarah L Braunstein
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

3.  Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations.

Authors:  Christina Mangurian; Priya Dahiya; Matthew L Goldman; Tom Corbeil; Melanie M Wall; Susan M Essock; Lisa B Dixon; Fei Tang; Eric Frimpong; Franco Mascayano; Marleen Radigan; Rui Wang; Mark Olfson; Thomas E Smith
Journal:  AIDS       Date:  2022-02-09       Impact factor: 4.632

4.  Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.

Authors:  Heather Bradley; Christine L Mattson; Linda Beer; Ping Huang; R Luke Shouse
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

5.  Continuum of Care Among People Living with Perinatally Acquired HIV Infection in New York City, 2014.

Authors:  Qiang Xia; Dipal Shah; Balwant Gill; Lucia V Torian; Sarah L Braunstein
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

6.  Impact of an HIV Care Coordination Program on Durable Viral Suppression.

Authors:  McKaylee M Robertson; Kate Penrose; Mary K Irvine; Rebekkah S Robbins; Sarah Kulkarni; Sarah L Braunstein; Levi Waldron; Graham Harriman; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

7.  The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.

Authors:  Daniel J Escudero; Mark N Lurie; Kenneth H Mayer; Maximilian King; Sandro Galea; Samuel R Friedman; Brandon D L Marshall
Journal:  BMC Public Health       Date:  2017-07-25       Impact factor: 3.295

8.  Redefining Prevention and Care: A Status-Neutral Approach to HIV.

Authors:  Julie E Myers; Sarah L Braunstein; Qiang Xia; Kathleen Scanlin; Zoe Edelstein; Graham Harriman; Benjamin Tsoi; Adriana Andaluz; Estella Yu; Demetre Daskalakis
Journal:  Open Forum Infect Dis       Date:  2018-05-02       Impact factor: 3.835

9.  Use of molecular HIV surveillance data and predictive modeling to prioritize persons for transmission-reduction interventions.

Authors:  Qiang Xia; Joel O Wertheim; Sarah L Braunstein; Kavita Misra; Chi-Chi Udeagu; Lucia V Torian
Journal:  AIDS       Date:  2020-03-01       Impact factor: 4.177

10.  Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study.

Authors:  James Wilton; Juan Liu; Ashleigh Sullivan; Beth Rachlis; Alex Marchand-Austin; Madison Giles; Lucia Light; Claudia Rank; Ann N Burchell; Sandra Gardner; Doug Sider; Mark Gilbert; Abigail E Kroch
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.